Avalo Therapeutics, Inc.
$19.59
-0.46 (-2.29%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +1.0%
- 3 Months
- +22.8%
- YTD
- +7.9%
- 1 Year
- +103.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 88.4%
- Largest decline max drawdown, since Aug 2025
- -44.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.22
Own AVTX?
See how AVTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.